ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Buclizine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-23G7992
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Buclizine Market Insights Forecast to 2028
BUY CHAPTERS

Global Buclizine Market Research Report 2025

Code: QYRE-Auto-23G7992
Report
July 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Stuart Pharmaceuticals
Laboratorios Rocnarf
UCB
Mankind Pharma
Johnson and Johnson
Meider Pharma
Sanofi
MK Pharma
HUA Shin Chemical Pharmaceutical
Peili Pharmaceutical
Pfizer Inc
Sinphar
Al Pharm

Buclizine Market Size

The global market for Buclizine was valued at US$ 662 million in the year 2024 and is projected to reach a revised size of US$ 885 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Buclizine Market

Buclizine Market

Buclizine is an antihistamine and anticholinergic of the diphenylmethylpiperazine group. It is considered to be an antiemetic, similar to meclizine.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Buclizine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buclizine.
The Buclizine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Buclizine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Buclizine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Buclizine Market Report

Report Metric Details
Report Name Buclizine Market
Accounted market size in year US$ 662 million
Forecasted market size in 2031 US$ 885 million
CAGR 4.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Stuart Pharmaceuticals, Laboratorios Rocnarf, UCB, Mankind Pharma, Johnson and Johnson, Meider Pharma, Sanofi, MK Pharma, HUA Shin Chemical Pharmaceutical, Peili Pharmaceutical, Pfizer, Sinphar, Al Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Buclizine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Buclizine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Buclizine Market growing?

Ans: The Buclizine Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Buclizine Market size in 2031?

Ans: The Buclizine Market size in 2031 will be US$ 885 million.

Who are the main players in the Buclizine Market report?

Ans: The main players in the Buclizine Market are Stuart Pharmaceuticals, Laboratorios Rocnarf, UCB, Mankind Pharma, Johnson and Johnson, Meider Pharma, Sanofi, MK Pharma, HUA Shin Chemical Pharmaceutical, Peili Pharmaceutical, Pfizer, Sinphar, Al Pharm

What are the Application segmentation covered in the Buclizine Market report?

Ans: The Applications covered in the Buclizine Market report are Antiallergic Agent, Histamine H₁-Receptor Antagonist

What are the Type segmentation covered in the Buclizine Market report?

Ans: The Types covered in the Buclizine Market report are Hospital, Drug Store

Recommended Reports

Pharmaceutical Therapies

Vaccine and Anti-infectives

CNS and Psychiatric Medication

1 Buclizine Market Overview
1.1 Product Definition
1.2 Buclizine by Type
1.2.1 Global Buclizine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hospital
1.2.3 Drug Store
1.3 Buclizine by Application
1.3.1 Global Buclizine Market Value by Application (2024 VS 2031)
1.3.2 Antiallergic Agent
1.3.3 Histamine H₁-Receptor Antagonist
1.4 Global Buclizine Market Size Estimates and Forecasts
1.4.1 Global Buclizine Revenue 2020-2031
1.4.2 Global Buclizine Sales 2020-2031
1.4.3 Global Buclizine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Buclizine Market Competition by Manufacturers
2.1 Global Buclizine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Buclizine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Buclizine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Buclizine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Buclizine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Buclizine, Product Type & Application
2.7 Global Key Manufacturers of Buclizine, Date of Enter into This Industry
2.8 Global Buclizine Market Competitive Situation and Trends
2.8.1 Global Buclizine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Buclizine Players Market Share by Revenue
2.8.3 Global Buclizine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Buclizine Market Scenario by Region
3.1 Global Buclizine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Buclizine Sales by Region: 2020-2031
3.2.1 Global Buclizine Sales by Region: 2020-2025
3.2.2 Global Buclizine Sales by Region: 2026-2031
3.3 Global Buclizine Revenue by Region: 2020-2031
3.3.1 Global Buclizine Revenue by Region: 2020-2025
3.3.2 Global Buclizine Revenue by Region: 2026-2031
3.4 North America Buclizine Market Facts & Figures by Country
3.4.1 North America Buclizine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Buclizine Sales by Country (2020-2031)
3.4.3 North America Buclizine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Buclizine Market Facts & Figures by Country
3.5.1 Europe Buclizine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Buclizine Sales by Country (2020-2031)
3.5.3 Europe Buclizine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Buclizine Market Facts & Figures by Region
3.6.1 Asia Pacific Buclizine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Buclizine Sales by Region (2020-2031)
3.6.3 Asia Pacific Buclizine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Buclizine Market Facts & Figures by Country
3.7.1 Latin America Buclizine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Buclizine Sales by Country (2020-2031)
3.7.3 Latin America Buclizine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Buclizine Market Facts & Figures by Country
3.8.1 Middle East and Africa Buclizine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Buclizine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Buclizine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Buclizine Sales by Type (2020-2031)
4.1.1 Global Buclizine Sales by Type (2020-2025)
4.1.2 Global Buclizine Sales by Type (2026-2031)
4.1.3 Global Buclizine Sales Market Share by Type (2020-2031)
4.2 Global Buclizine Revenue by Type (2020-2031)
4.2.1 Global Buclizine Revenue by Type (2020-2025)
4.2.2 Global Buclizine Revenue by Type (2026-2031)
4.2.3 Global Buclizine Revenue Market Share by Type (2020-2031)
4.3 Global Buclizine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Buclizine Sales by Application (2020-2031)
5.1.1 Global Buclizine Sales by Application (2020-2025)
5.1.2 Global Buclizine Sales by Application (2026-2031)
5.1.3 Global Buclizine Sales Market Share by Application (2020-2031)
5.2 Global Buclizine Revenue by Application (2020-2031)
5.2.1 Global Buclizine Revenue by Application (2020-2025)
5.2.2 Global Buclizine Revenue by Application (2026-2031)
5.2.3 Global Buclizine Revenue Market Share by Application (2020-2031)
5.3 Global Buclizine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Stuart Pharmaceuticals
6.1.1 Stuart Pharmaceuticals Company Information
6.1.2 Stuart Pharmaceuticals Description and Business Overview
6.1.3 Stuart Pharmaceuticals Buclizine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Stuart Pharmaceuticals Buclizine Product Portfolio
6.1.5 Stuart Pharmaceuticals Recent Developments/Updates
6.2 Laboratorios Rocnarf
6.2.1 Laboratorios Rocnarf Company Information
6.2.2 Laboratorios Rocnarf Description and Business Overview
6.2.3 Laboratorios Rocnarf Buclizine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Laboratorios Rocnarf Buclizine Product Portfolio
6.2.5 Laboratorios Rocnarf Recent Developments/Updates
6.3 UCB
6.3.1 UCB Company Information
6.3.2 UCB Description and Business Overview
6.3.3 UCB Buclizine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 UCB Buclizine Product Portfolio
6.3.5 UCB Recent Developments/Updates
6.4 Mankind Pharma
6.4.1 Mankind Pharma Company Information
6.4.2 Mankind Pharma Description and Business Overview
6.4.3 Mankind Pharma Buclizine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mankind Pharma Buclizine Product Portfolio
6.4.5 Mankind Pharma Recent Developments/Updates
6.5 Johnson and Johnson
6.5.1 Johnson and Johnson Company Information
6.5.2 Johnson and Johnson Description and Business Overview
6.5.3 Johnson and Johnson Buclizine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Johnson and Johnson Buclizine Product Portfolio
6.5.5 Johnson and Johnson Recent Developments/Updates
6.6 Meider Pharma
6.6.1 Meider Pharma Company Information
6.6.2 Meider Pharma Description and Business Overview
6.6.3 Meider Pharma Buclizine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Meider Pharma Buclizine Product Portfolio
6.6.5 Meider Pharma Recent Developments/Updates
6.7 Sanofi
6.7.1 Sanofi Company Information
6.7.2 Sanofi Description and Business Overview
6.7.3 Sanofi Buclizine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanofi Buclizine Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 MK Pharma
6.8.1 MK Pharma Company Information
6.8.2 MK Pharma Description and Business Overview
6.8.3 MK Pharma Buclizine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 MK Pharma Buclizine Product Portfolio
6.8.5 MK Pharma Recent Developments/Updates
6.9 HUA Shin Chemical Pharmaceutical
6.9.1 HUA Shin Chemical Pharmaceutical Company Information
6.9.2 HUA Shin Chemical Pharmaceutical Description and Business Overview
6.9.3 HUA Shin Chemical Pharmaceutical Buclizine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 HUA Shin Chemical Pharmaceutical Buclizine Product Portfolio
6.9.5 HUA Shin Chemical Pharmaceutical Recent Developments/Updates
6.10 Peili Pharmaceutical
6.10.1 Peili Pharmaceutical Company Information
6.10.2 Peili Pharmaceutical Description and Business Overview
6.10.3 Peili Pharmaceutical Buclizine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Peili Pharmaceutical Buclizine Product Portfolio
6.10.5 Peili Pharmaceutical Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Company Information
6.11.2 Pfizer Description and Business Overview
6.11.3 Pfizer Buclizine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Pfizer Buclizine Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Sinphar
6.12.1 Sinphar Company Information
6.12.2 Sinphar Description and Business Overview
6.12.3 Sinphar Buclizine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sinphar Buclizine Product Portfolio
6.12.5 Sinphar Recent Developments/Updates
6.13 Al Pharm
6.13.1 Al Pharm Company Information
6.13.2 Al Pharm Description and Business Overview
6.13.3 Al Pharm Buclizine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Al Pharm Buclizine Product Portfolio
6.13.5 Al Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Buclizine Industry Chain Analysis
7.2 Buclizine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Buclizine Production Mode & Process Analysis
7.4 Buclizine Sales and Marketing
7.4.1 Buclizine Sales Channels
7.4.2 Buclizine Distributors
7.5 Buclizine Customer Analysis
8 Buclizine Market Dynamics
8.1 Buclizine Industry Trends
8.2 Buclizine Market Drivers
8.3 Buclizine Market Challenges
8.4 Buclizine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Stuart Pharmaceuticals
Laboratorios Rocnarf
UCB
Mankind Pharma
Johnson and Johnson
Meider Pharma
Sanofi
MK Pharma
HUA Shin Chemical Pharmaceutical
Peili Pharmaceutical
Pfizer Inc
Sinphar
Al Pharm
List of Tables
 Table 1. Global Buclizine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Buclizine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Buclizine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Buclizine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Buclizine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Buclizine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Buclizine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Buclizine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Buclizine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Buclizine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Buclizine, Product Type & Application
 Table 12. Global Key Manufacturers of Buclizine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Buclizine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Buclizine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Buclizine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Buclizine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Buclizine Sales Market Share by Region (2020-2025)
 Table 19. Global Buclizine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Buclizine Sales Market Share by Region (2026-2031)
 Table 21. Global Buclizine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Buclizine Revenue Market Share by Region (2020-2025)
 Table 23. Global Buclizine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Buclizine Revenue Market Share by Region (2026-2031)
 Table 25. North America Buclizine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Buclizine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Buclizine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Buclizine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Buclizine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Buclizine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Buclizine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Buclizine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Buclizine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Buclizine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Buclizine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Buclizine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Buclizine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Buclizine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Buclizine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Buclizine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Buclizine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Buclizine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Buclizine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Buclizine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Buclizine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Buclizine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Buclizine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Buclizine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Buclizine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Buclizine Sales (K Units) by Type (2020-2025)
 Table 51. Global Buclizine Sales (K Units) by Type (2026-2031)
 Table 52. Global Buclizine Sales Market Share by Type (2020-2025)
 Table 53. Global Buclizine Sales Market Share by Type (2026-2031)
 Table 54. Global Buclizine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Buclizine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Buclizine Revenue Market Share by Type (2020-2025)
 Table 57. Global Buclizine Revenue Market Share by Type (2026-2031)
 Table 58. Global Buclizine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Buclizine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Buclizine Sales (K Units) by Application (2020-2025)
 Table 61. Global Buclizine Sales (K Units) by Application (2026-2031)
 Table 62. Global Buclizine Sales Market Share by Application (2020-2025)
 Table 63. Global Buclizine Sales Market Share by Application (2026-2031)
 Table 64. Global Buclizine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Buclizine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Buclizine Revenue Market Share by Application (2020-2025)
 Table 67. Global Buclizine Revenue Market Share by Application (2026-2031)
 Table 68. Global Buclizine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Buclizine Price (US$/Unit) by Application (2026-2031)
 Table 70. Stuart Pharmaceuticals Company Information
 Table 71. Stuart Pharmaceuticals Description and Business Overview
 Table 72. Stuart Pharmaceuticals Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Stuart Pharmaceuticals Buclizine Product
 Table 74. Stuart Pharmaceuticals Recent Developments/Updates
 Table 75. Laboratorios Rocnarf Company Information
 Table 76. Laboratorios Rocnarf Description and Business Overview
 Table 77. Laboratorios Rocnarf Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Laboratorios Rocnarf Buclizine Product
 Table 79. Laboratorios Rocnarf Recent Developments/Updates
 Table 80. UCB Company Information
 Table 81. UCB Description and Business Overview
 Table 82. UCB Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. UCB Buclizine Product
 Table 84. UCB Recent Developments/Updates
 Table 85. Mankind Pharma Company Information
 Table 86. Mankind Pharma Description and Business Overview
 Table 87. Mankind Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Mankind Pharma Buclizine Product
 Table 89. Mankind Pharma Recent Developments/Updates
 Table 90. Johnson and Johnson Company Information
 Table 91. Johnson and Johnson Description and Business Overview
 Table 92. Johnson and Johnson Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Johnson and Johnson Buclizine Product
 Table 94. Johnson and Johnson Recent Developments/Updates
 Table 95. Meider Pharma Company Information
 Table 96. Meider Pharma Description and Business Overview
 Table 97. Meider Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Meider Pharma Buclizine Product
 Table 99. Meider Pharma Recent Developments/Updates
 Table 100. Sanofi Company Information
 Table 101. Sanofi Description and Business Overview
 Table 102. Sanofi Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Sanofi Buclizine Product
 Table 104. Sanofi Recent Developments/Updates
 Table 105. MK Pharma Company Information
 Table 106. MK Pharma Description and Business Overview
 Table 107. MK Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. MK Pharma Buclizine Product
 Table 109. MK Pharma Recent Developments/Updates
 Table 110. HUA Shin Chemical Pharmaceutical Company Information
 Table 111. HUA Shin Chemical Pharmaceutical Description and Business Overview
 Table 112. HUA Shin Chemical Pharmaceutical Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. HUA Shin Chemical Pharmaceutical Buclizine Product
 Table 114. HUA Shin Chemical Pharmaceutical Recent Developments/Updates
 Table 115. Peili Pharmaceutical Company Information
 Table 116. Peili Pharmaceutical Description and Business Overview
 Table 117. Peili Pharmaceutical Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Peili Pharmaceutical Buclizine Product
 Table 119. Peili Pharmaceutical Recent Developments/Updates
 Table 120. Pfizer Company Information
 Table 121. Pfizer Description and Business Overview
 Table 122. Pfizer Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Pfizer Buclizine Product
 Table 124. Pfizer Recent Developments/Updates
 Table 125. Sinphar Company Information
 Table 126. Sinphar Description and Business Overview
 Table 127. Sinphar Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Sinphar Buclizine Product
 Table 129. Sinphar Recent Developments/Updates
 Table 130. Al Pharm Company Information
 Table 131. Al Pharm Description and Business Overview
 Table 132. Al Pharm Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Al Pharm Buclizine Product
 Table 134. Al Pharm Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Buclizine Distributors List
 Table 138. Buclizine Customers List
 Table 139. Buclizine Market Trends
 Table 140. Buclizine Market Drivers
 Table 141. Buclizine Market Challenges
 Table 142. Buclizine Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Buclizine
 Figure 2. Global Buclizine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Buclizine Market Share by Type: 2024 & 2031
 Figure 4. Hospital Product Picture
 Figure 5. Drug Store Product Picture
 Figure 6. Global Buclizine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Buclizine Market Share by Application: 2024 & 2031
 Figure 8. Antiallergic Agent
 Figure 9. Histamine H₁-Receptor Antagonist
 Figure 10. Global Buclizine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Buclizine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Buclizine Sales (2020-2031) & (K Units)
 Figure 13. Global Buclizine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Buclizine Report Years Considered
 Figure 15. Buclizine Sales Share by Manufacturers in 2024
 Figure 16. Global Buclizine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Buclizine Players: Market Share by Revenue in Buclizine in 2024
 Figure 18. Buclizine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Buclizine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Buclizine Sales Market Share by Country (2020-2031)
 Figure 21. North America Buclizine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Buclizine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Buclizine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Buclizine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Buclizine Revenue Market Share by Region (2020-2031)
 Figure 33. China Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Buclizine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Buclizine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Buclizine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Buclizine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Buclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Buclizine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Buclizine by Type (2020-2031)
 Figure 54. Global Buclizine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Buclizine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Buclizine by Application (2020-2031)
 Figure 57. Global Buclizine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Buclizine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Cetirizine Dihydrochloride Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nausea And Vomiting Treatment Market Insights Forecast to 2030
Cinnarizine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mizolastine Market Research Report 2024
Cetirizine Hydrochloride Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antazoline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Dicyclomine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Emetic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Azelastine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hydroxyethyl Piperazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Levocetirizine Hydrochloride Capsules Market Research Report 2024
Triprolidine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Levocetirizine Hydrochloride Tablets Market Research Report 2024
Diphenylpyraline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Doxylamine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cyclizine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Levocetirizine Drug Market Insights Forecast to 2030
Global Antihistamine Medications Market Research Report 2025
Lysine Chloride Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharma and Cetirizine OTC Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions